GLT8D2 and ovarian carcinoma: As shown in Fig. 5a, b, the chemoresistance effect of GLT8D2 in ovarian cancer cells was significantly inhibited by treatment with a FGFR inhibitor or AKT inhibitor (GDC-0068) (PMID: 23287563).